Published in
Elsevier, Molecular Genetics and Metabolism Reports, (27), p. 100758, 2021
DOI: 10.1016/j.ymgmr.2021.100758
Links
Tools
Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II
Journal article published in 2021 by
Ryuji Yamamoto,
Eiji Yoden,
Noboru Tanaka,
Masafumi Kinoshita,
Atsushi Imakiire,
Tohru Hirato,
Kohtaro Minami 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 